Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Z Gastroenterol

Retrieve available abstracts of 21 articles:
HTML format
Text format



Single Articles


    July 2019
  1. BRANDES A, Groth A, Gottschalk F, Wilke T, et al
    Real-world biologic treatment and associated cost in patients with inflammatory bowel disease.
    Z Gastroenterol. 2019;57:843-851.
    PubMed     Text format     Abstract available


    April 2019
  2. STALLMACH A, Grunert P, Pieper D, Steube A, et al
    [Ulcerative colitis: Does the modulation of gut microbiota induce long-lasting remission?]
    Z Gastroenterol. 2019 Apr 15. doi: 10.1055/a-0874-6603.
    PubMed     Text format     Abstract available


  3. PETRUO VA, Krauss E, Kleist A, Hardt J, et al
    Perceived distress, personality characteristics, coping strategies and psychosocial impairments in a national German multicenter cohort of patients with Crohn's disease and ulcerative colitis.
    Z Gastroenterol. 2019;57:473-483.
    PubMed     Text format     Abstract available


    March 2019
  4. ROGGENBROD S, Schuler C, Haller B, Sohn M, et al
    [Patient perception and approval of fecal microbiota transplantation (FMT) as an alternative treatment option for ulcerative colitis].
    Z Gastroenterol. 2019;57:296-303.
    PubMed     Text format     Abstract available


    January 2019

  5. Updated S3-Guideline Ulcerative Colitis. German Society for Digestive and Metabolic Diseases (DGVS).
    Z Gastroenterol. 2019 Jan 17. doi: 10.1055/a-0824-0861.
    PubMed     Text format     Abstract available


    November 2018
  6. METZGER JC, Kurz E, von Spee-Mayer C, Kolck G, et al
    [Chronic granulomatous disease as a rare differential diagnosis of inflammatory bowel disease].
    Z Gastroenterol. 2018 Nov 22. doi: 10.1055/a-0732-5865.
    PubMed     Text format     Abstract available


  7. STALLMACH A, Reuken PA, Teich N
    [Advances in the diagnosis and treatment of Clostridioides [Clostridium] difficile infections in inflammatory bowel disease].
    Z Gastroenterol. 2018;56:1369-1377.
    PubMed     Text format     Abstract available


    May 2018
  8. HUPPE A, Langbrandtner J, Hauser W, Raspe H, et al
    Validation of the "German Inflammatory Bowel Disease Activity Index (GIBDI)": An Instrument for Patient-Based Disease Activity Assessment in Crohn's Disease and Ulcerative Colitis.
    Z Gastroenterol. 2018 May 9. doi: 10.1055/a-0605-4080.
    PubMed     Text format     Abstract available


  9. SCHNEIDER A, Hirth M, Weiss C, Weidner P, et al
    Prevalence of inflammatory bowel disease in alcoholic, non-alcoholic and autoimmune pancreatitis.
    Z Gastroenterol. 2018;56:469-478.
    PubMed     Text format     Abstract available


    February 2018
  10. STALLMACH A, Anttila VJ, Hell M, Gwynn S, et al
    Inflammatory bowel disease and Clostridium difficile infection: contrasting views of international clinical professionals.
    Z Gastroenterol. 2018 Feb 9. doi: 10.1055/s-0044-100045.
    PubMed     Text format     Abstract available


  11. NOWACKI TM, Bettenworth D
    [When to operate Crohn's disease patients with ileocaecal manifestation ?]
    Z Gastroenterol. 2018;56:165-167.
    PubMed     Text format    


    December 2017
  12. MOGL MT, Baumgart DC, Fischer A, Pratschke J, et al
    Immunosuppression following liver transplantation and the course of inflammatory bowel disease - a case control study.
    Z Gastroenterol. 2017 Dec 6. doi: 10.1055/s-0043-117183.
    PubMed     Text format     Abstract available


    August 2017
  13. REINSHAGEN M, Stallmach A
    [Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial].
    Z Gastroenterol. 2017;55:779-780.
    PubMed     Text format    


    June 2017
  14. MONASTERIO C, Schmitt-Graff A, Pohl M, Truschel T, et al
    Fatal ulcerative enteritis of the small intestine in a patient with ulcerative colitis treated with vedolizumab.
    Z Gastroenterol. 2017 Jun 27. doi: 10.1055/s-0043-111805.
    PubMed     Text format     Abstract available


    January 2017
  15. BOKEMEYER B, Dignass A, Schreiber S
    [Biosimilars in Inflammatory Bowel Disease (IBD): Experiences and perceptions of german gastroenterologists].
    Z Gastroenterol. 2017 Jan 5. doi: 10.1055/s-0042-121520.
    PubMed     Text format     Abstract available


  16. HELWIG U
    [Relapse after withdrawal from anti-TNF therapy for inflammatory bowel disease].
    Z Gastroenterol. 2017;55:85.
    PubMed     Text format    


    December 2016
  17. BETTENWORTH D
    [Evolution of clinical trial design investigating biological therapies in patients with inflammatory bowel disease - implications for clinical practic].
    Z Gastroenterol. 2016.
    PubMed     Text format    


    October 2016
  18. SIEGMUND B, Atreya R, Bokemeyer B, Kruis W, et al
    [Biosimilars in inflammatory bowel disease].
    Z Gastroenterol. 2016.
    PubMed     Text format     Abstract available


  19. GEHRMANN U, Berger U, Teich N, Bruns T, et al
    Motivation of patients with inflammatory bowel disease to participate in a clinical trial.
    Z Gastroenterol. 2016;54:1123-1129.
    PubMed     Text format     Abstract available


    September 2016
  20. RUDDEL J, Schleenvoigt BT, Schuler E, Schmidt C, et al
    Yellow fever vaccination during treatment with infliximab in a patient with ulcerative colitis: A case report.
    Z Gastroenterol. 2016;54:1081-4.
    PubMed     Text format     Abstract available


    February 2016
  21. LANGBRANDTNER J, Raspe H, Huppe A
    [Employees with chronic diseases - additional results of randomized controlled trial among adult members of a German statutory health insurance with inflammatory bowel diseases].
    Z Gastroenterol. 2016;54:139-45.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: